Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients

M.M. Malingré, J.H. Beijnen, H. Rosing, W.W. ten Bokkel Huinink, J.H.M. Schellens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)42-47
Number of pages6
JournalBritish Journal of Cancer
Volume84
Publication statusPublished - 2001

Cite this